TerrAscend (TSNDF) Depreciation and Depletion (2021 - 2026)
TerrAscend's (TSNDF) quarterly Depreciation and Depletion came in at $2.4 million in Q1 2026, down 1.75% year-on-year from $2.4 million in Q1 2025, and up 2.74% on a QoQ basis from $2.3 million in Q4 2025.
TerrAscend (TSNDF) Depreciation and Depletion (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Depreciation and Depletion data on file, last reported at $2.4 million in Q1 2026.
- On a quarterly basis, Depreciation and Depletion fell 1.75% year-over-year to $2.4 million in Q1 2026; TTM through Mar 2026 was $9.1 million, a 0.46% change from a year earlier, with the FY2025 full-year figure at $9.1 million, up 2.09% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $2.4 million, up from $2.3 million in the prior quarter.
- Over the last five years, Depreciation and Depletion for TSNDF reached as high as $3.4 million in Q2 2023 and fell as low as -$1.0 million in Q4 2023.
- Historically, Depreciation and Depletion has averaged $2.3 million across 5 years, with a median of $2.4 million in 2026.
- Across the five-year window, Depreciation and Depletion soared 986.94% in 2022 and plunged 142.93% in 2023, its largest moves.
- Year by year, Depreciation and Depletion stood at $2.4 million in 2022, then sank by 142.93% to -$1.0 million in 2023, then surged by 322.3% to $2.3 million in 2024, then retreated by 0.09% to $2.3 million in 2025, then advanced by 2.74% to $2.4 million in 2026.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were $2.4 million in Q1 2026, $2.3 million in Q4 2025, and $2.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 2.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.36 Mn |
| Mar 31, 2026 | 2.36 Mn |
| Dec 31, 2025 | 2.30 Mn |
| Dec 31, 2025 | 2.30 Mn |
| Sep 30, 2025 | 2.20 Mn |
| Sep 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 2.24 Mn |
| Jun 30, 2025 | 2.24 Mn |
| Mar 31, 2025 | 2.41 Mn |
| Mar 31, 2025 | 2.41 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Mar 31, 2024 | 3.04 Mn |
| Mar 31, 2024 | 3.04 Mn |
| Dec 31, 2023 | -1.04 Mn |
| Dec 31, 2023 | -1.04 Mn |